Article: AAV-based gene therapies hold promise for treating CNS conditions
Meaningful progress is being made in the development of gene therapies for rare neurological diseases caused by single gene mutations. AAV-based therapeutics have been the most successful in vivo gene therapies for patients with central nervous system disorders. Precision’s Deb Phippard identifies challenges to their development with assessing, minimizing and mitigating immunogenicity.
Article: Breaking barriers: strategies for expanding patient access to cell and gene therapies
Despite a potentially record-breaking year for the cell and gene therapy industry, certain challenges remain. Precision’s Anshul Mangal identifies ways innovation can overcome hurdles that may ultimately stand in the way of broader accessibility.
Conference: Advanced Therapies Week, 2024
Precision will be at this year’s Advanced Therapies Week, January 16 – 19, in Miami, FL. Connect with our team of experts as they lead meaningful presentations and discussions throughout this event providing insights into the clinical development, manufacturing, and commercialization for advanced therapies.
Speaking Engagements
Detailed descriptions for each speaking engagement are included below.
- Precision will chair the opening plenary session on January 17, 2024, 9:00 – 10:30 am.
- Precision will chair panel discussion ‘Non-Viral Solutions for Gene Therapy’ on January 19, 2024, 10:00 – 11:00 am.
- Project Farma will sponsor the ‘Yacht Party – Under The Stars’ on January 17, 2024, 7:30 – 9:00 pm.
- Precision will host the opening remarks and present the Cell Therapy Biotech Innovation Award at the Advanced Therapies Awards Ceremony on January 18, 2024.
Connect with our Advanced Therapy experts
- Visit us through any of the numerous networking opportunities at Advanced Therapies Week
- Be sure to attend the Project Farma sponsored ‘Yacht Party – Under The Stars’ on January 17, 2024, 7:00 – 9:30 pm
- Join us for the Advanced Therapies Awards Ceremony on January 18, 2024, 7:00 pm – 12:00 am
- Schedule an in-person or virtual meeting with our team
You can register for Advanced Therapies Week below:
Precision Medicine Group Releases Its Inaugural Environmental, Social and Governance (ESG) Report
Precision is proud to have published our inaugural 2023 Environmental, Social and Governance (ESG) Report, reflecting the company’s ongoing efforts to do better for our people, in our practices, and with the broader community at large. This year’s report shares key achievements, performance metrics, and steps we have taken to enhance sustainability throughout the company, including:
· Engaging internal and external stakeholders in our company’s first ESG materiality assessment to identify and prioritize our material issues
· Defining Precision’s approach to ESG in our company’s ESG Strategy Statement · Creating a three-year strategic ESG Roadmap for advancing our performance across environmental, social, and governance issues · Initiating energy efficiency projects and standards across our facilities
· Implementing implicit bias training for our Executive Leadership Team and Human Resources leaders
· Contributing volunteer hours by over 425 employees and over $250,000 in donations to more than 70 charitable foundations and causes
Article: Generative AI Holds the Key to Transforming Trial Design
Recent AI applications rely heavily on predictive AI, which harnesses historical data to make predictions and recommendations for the future. But what is really propelling the industry forward is generative AI, which uses models or algorithms to create various types of content using learned patterns based on the data on which it was trained.
SVP/Chief Architect Tobias Guennel outlines how generative AI will speed up clinical trial execution as sponsors integrate AI-enabled technologies into their day-to-day workflows.